Register for OBR daily

Kantar Health Conference Sidebar

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

CBMG $35.04 8.8709 +33.90%
EXEL $4.42 0.2250 +5.37%
NYMX $5.04 0.1399 +2.86%
CLSN $3.48 0.0900 +2.65%
Kite $22.40 0.3800 +1.73%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

ARRY $3.94 -0.2400 -5.74%
ONTY $2.85 -0.1600 -5.32%
GALT $14.51 -0.8115 -5.30%
TGTX $8.00 -0.4400 -5.21%
KPTI $34.68 -1.9000 -5.19%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 877 | 878 | 879 | 880 | 881 | 882 | 883 | 884 | 885 | 886 | Next > | Last >>

New Breast Cancer Drug Found Deep In the Sea

(Wall Street Journal) Jan 4, 2011 - Amid a dry spell for breakthrough cancer drugs, recent U.S. approval of Eisai Co.'s Halaven represents some vindication for a small group of researchers who believe, contrary to recent pharmaceutical fashion, that molecules from nature hold promise against hard-to-treat diseases.
read article (paid subscription required) 

Celgene Files For Additional Approvals Of Revlimid, Istodax

(Dow Jones Newswires/NASDAQ) Jan 4, 2011 - Celgene Corp. said it has submitted blood cancer therapies Revlimid and Istodax for new approvals in Europe and the U.S.
read article 

Study: Colonoscopy Is Worth the Discomfort

(Time Healthland) Jan 3, 2011 - Screening for cancer is the best way to prevent many forms of the disease, particularly in skin and breast tissue, among other cancers, but the tests aren't always the easiest to endure.
read article 

Average Child May Get Seven Radiation Scans by Age 18

(AP/Denver Post) Jan 3, 2011 - The first large study to examine the use of X-rays, CT scans and other medical radiation in children estimates the average child will get more than seven radiation scans by age 18, a potentially worrisome trend.
read article 

Estrogen May Play Role in Rising Rates of Head, Neck Cancer

(U.S. News & World Report) Jan 4, 2011 - Rates of head and neck cancer are rising among some groups of people, including young women without any known risk factors. Now, a study suggests that estrogen may help the cancer spread by boosting the movement of precancerous cells in the mouth.
read article 

Advancements in Fertility Preservation Provide Oncology Patients New Options

(Mayo Clinic) Jan 3, 2011 - Many young people who've just learned that they have cancer also are told that the therapies that may save their lives could rob them of their ability ever to have children.
read press release 

Protein Wields Phosphate Group to Inhibit Cancer Metastasis

(MD Anderson) Jan 3, 2011 - By sticking a chemical group to it at a specific site, a protein arrests an enzyme that may worsen and spread cancer, an international research team led by scientists at The University of Texas MD Anderson Cancer Center reports in the January issue of Nature Cell Biology.
read press release 

Parallels Between Cancers, Infection Suppression Reported

(The City College of New York) Jan 3, 2011 - Same proteins involved, but cancer takes hold when response gets out of control, CCNY biologists report.
read press release 

Isis Initiates Broad Phase 2 Program of ISIS-EIF4ERx in Cancer

(Isis) Jan 4, 2011- Isis Pharmaceuticals, Inc. announced the initiation of two Phase 2 studies of ISIS-EIF4ERx in patients with non-small cell lung cancer and prostate cancer.
read press release 

Vaccinex, Inc. Initiates Clinical Trial of Novel Therapeutic Antibody in Cancer Patients With Advanced Solid Tumors

(Yahoo! Finance) Jan 4, 2011 - Vaccinex, Inc. announced today that it has received clearance from FDA and will initiate a Phase 1 clinical trial to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of therapeutic antibody candidate VX15/2503 in cancer patients with advanced solid tumors.
read article 

Spectrum Pharmaceuticals Submits Supplemental New Drug Application (sNDA) for Ready-to-Use Formulation of FUSILEV(r) in Colorectal Cancer

(SmartBrief) Jan 4, 2011 - Spectrum Pharmaceuticals today announced it submitted a supplemental New Drug Application with the U.S. Food and Drug Administration (FDA) for a Ready-to-Use formulation of FUSILEV (levoleucovorin) for Injection.
read article 

Foundation Medicine Announces First Large Pharmaceutical Company Collaboration

(Foundation Medicine) Jan 4, 2011 - Foundation Medicine, Inc., a personalized cancer medicine company that aims to bring comprehensive cancer genome analysis to routine clinical care, today announced a strategic pilot collaboration with Novartis to develop, enhance and optimize Foundation Medicine’s cancer genome panel test for Novartis’ needs.
download pdf 

Mercator, Pepscan Partner on Cancer Therapy Developments

(Mass High Tech) Jan 3, 2011 - Waltham biotech startup Mercator Therapeutics Inc. has entered into a research and licensing collaboration with Pepscan Therapeutics, a Dutch protein technology firm, to develop cancer therapeutics.
read article 

Cancer Centers of North Carolina - Asheville Implements iKnowMed(tm) Electronic Medical Record (EMR) from US Oncology

(US Oncology) Jan 4, 2011 - Cancer Centers of North Carolina - Asheville (CCNCA), an affiliate of the United Network of US Oncology with two practices serving North Carolina, today announced that it has implemented iKnowMed(tm) EMR for its electronic medical record (EMR) system.
read press release 

Biomoda Names New Chief Executive Officer

(CNBC) Jan 4, 2011 - Cancer diagnostics company Biomoda, Inc. announced that Maria Zannes, chairman of the board of directors, has been appointed chief executive officer, effective immediately. John Cousins will continue to serve as company president and chief financial officer.
read article 

ZIOPHARM Oncology Appoints Mark Thornton, M.D., Ph.D., as Executive Vice President and Chief Development Officer

(Yahoo! Finance) Jan 4, 2011 - ZIOPHARM Oncology, Inc. announced today that it has appointed Mark O. Thornton, M.D., Ph.D., Executive Vice President and Chief Development Officer.
read article 

Doctors Knew How to Treat My Cancer, But It Took Years to Control My Itching

(Washington Post) Jan 3, 2011 - The itching that accompanied the appearance of a splotchy rash along my belt line in 2003 seemed only a minor annoyance at first...It turned out I had a little-known form of cancer - which understandably became the focus of treatment.
read article (free registration required) 

At Novartis, a Winning Formula

(Boston Globe) Jan 4, 2011 - Mark Fishman’s strategy seems to be working. Last year alone, Novartis won Food and Drug Administration approval for four new drugs, including Afinitor, the first medication for patients with benign brain tumors associated with tuberous sclerosis.
read article (free registration required) 

Suggestions for Making Prescription-Drug Labels More Clear

(WSJ Health Blog) Jan 3, 2011 - A report by the Institute of Medicine estimates that 90 million Americans can’t fully understand and act upon health information.
read article (paid subscription required) 

Pfizer, Santaris Expand RNA-Therapy Collaboration Pact

(Dow Jones Newswires/Morningstar) Jan 4, 2011 - Pfizer Inc. has expanded its collaboration with drug maker Santaris Pharma A/S, agreeing to an expanded development and commercialization pact that could see it paying as much as $600 million.
read article 

Blood Test to Spot Cancer Gets Big Boost From J&J

(ABC News) Jan 3, 2011 - A blood test so sensitive that it can spot a single cancer cell lurking among a billion healthy ones is moving one step closer to being available at your doctor's office.
read article 

Drug Approvals Slipped in 2010

(Wall Street Journal) Dec 31, 2010 - The Food and Drug Administration approved about 21 drugs in 2010, a relatively modest figure that shows the pharmaceutical industry hasn't yet escaped its drought in recent years.
read article (paid subscription required) 

More Signs Lung Cancer Screening Could Save Lives

(Reuters) Dec 28, 2010 - More research is suggesting that heavy smokers may benefit from screening for lung cancer, to detect tumors in their earliest stages.
read article 

Obama Returns to End-of-Life Plan That Caused Stir

(New York Times) Dec 25, 2010 - When a proposal to encourage end-of-life planning touched off a political storm over “death panels,” Democrats dropped it from legislation to overhaul the health care system. But the Obama administration will achieve the same goal by regulation, starting Jan. 1.
read article (free registration required) 

Glaxo's Kidney-Cancer Drug Votrient Wins U.K. Backing With Price Agreement

(Bloomberg) Dec 23, 2010 - GlaxoSmithKline Plc, Europe’s second-largest drugmaker by sales, won the backing of the U.K. National Institute for Health and Clinical Excellence for the Votrient kidney-cancer pill after agreeing to lower the price.
read article